- Release Date: 14/09/20 08:41
- Summary: Recovery from COVID-19 tracking ahead of expectations
- Price Sensitive: No
- Download Document 151.47KB
- Forums
- ASX - By Stock
- ARX
- Ann: Recovery from COVID-19 tracking ahead of expectations
ARX
aroa biosurgery limited
Add to My Watchlist
2.61%
!
59.0¢

Ann: Recovery from COVID-19 tracking ahead of expectations
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
59.0¢ |
Change
0.015(2.61%) |
Mkt cap ! $203.5M |
Open | High | Low | Value | Volume |
57.5¢ | 59.0¢ | 57.0¢ | $65.79K | 113.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4850 | 58.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 17063 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 0.580 |
1 | 12000 | 0.570 |
2 | 18503 | 0.550 |
3 | 21703 | 0.540 |
1 | 12688 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 10063 | 1 |
0.595 | 25665 | 3 |
0.605 | 50000 | 1 |
0.650 | 12500 | 2 |
0.680 | 15000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ARX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online